Ibnsina Pharma (CAI:ISPH) Institutional Ownership: 0.53% (As of Sep. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAI:ISPH Ibnsina Pharma CAI:ISPH
82 GF Score
Price E£13.15
GF Value E£11.67
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Ibnsina Pharma Institutional Ownership?

Ibnsina Pharma CAI:ISPH +1.54% 82 Institutional Ownership is 0.53% as of Sep. 05, 2026. GuruFocus rates CAI:ISPH with a GF Score™ of 82/100 and a GF Value™ of E£11.67 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Ibnsina Pharma's institutional ownership is 0.53%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Ibnsina Pharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Ibnsina Pharma's Float Percentage Of Total Shares Outstanding is 0.00%.

Ibnsina Pharma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Ibnsina Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ibnsina Pharma Institutional Ownership Chart

Ibnsina Pharma Historical Data

The historical data trend for Ibnsina Pharma can be seen below:

2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 0.46 0.47 0.55 0.56 0.36 0.44 0.44 0.53 0.53 0.53
CAI:ISPH
82GF Score
Ibnsina Pharma CAI:ISPH
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ibnsina Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.53% mean?
Ibnsina Pharma (CAI:ISPH) has a Institutional Ownership of 0.53% as of Sep. 05, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Ibnsina Pharma and its competitors.
Is Ibnsina Pharma's Institutional Ownership too high?
Ibnsina Pharma's current Institutional Ownership is 0.53%. Overall, Ibnsina Pharma has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ibnsina Pharma's Institutional Ownership compare to MCK and COR?
Ibnsina Pharma's Institutional Ownership of 0.53% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Distribution company?
A good Institutional Ownership depends on the Medical Distribution industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Ibnsina Pharma and its competitors. Ibnsina Pharma's current Institutional Ownership is 0.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ibnsina Pharma stock overvalued right now?
Based on GuruFocus' analysis, Ibnsina Pharma (CAI:ISPH) is currently considered Modestly Overvalued. The stock's GF Value™ is E£11.67, compared to a current price of E£13.15 — trading 12.7% above its estimated fair value. The current Institutional Ownership is 0.53%. Ibnsina Pharma's overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Ibnsina Pharma (CAI:ISPH), the current Institutional Ownership is 0.53% as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ibnsina Pharma (CAI:ISPH) Overvalued in 2026?

Based on GuruFocus' analysis, Ibnsina Pharma stock appears to be overvalued. The current stock price of E£13.15 is trading 12.7% above its estimated GF Value™ of E£11.67. GuruFocus considers Ibnsina Pharma to be Modestly Overvalued.

Key valuation signals for CAI:ISPH:

  • Institutional Ownership: 0.53%
  • GF Value™: E£11.67 vs. price of E£13.15 (12.7% above fair value)
  • GF Score™: 82/100 with 8 warning signs

No single metric tells the full story. See the CAI:ISPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ibnsina Pharma Business Description

Address Industrial zone 1, PO box 91, Obour, EGY
Ibnsina Pharma is an Egypt-based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical, and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, packaging, market research, and analysis.
82GF Score

Get the complete analysis for CAI:ISPH

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£13.15
Price
E£11.67
GF Value